Novartis is proud to be a leader within the life sciences industry within the UK. Our focus is on innovating to address the most significant unmet needs of patients and societies in the UK and worldwide.
Our UK head office, currently located in Frimley, Surrey, is soon to relocate to London. We will join several other biotechnology companies in the emerging life sciences cluster of White City. Also home to Imperial College London’s new research and innovation campus, the move will allow us to network and collaborate with like-minded members of the life sciences ecosystem.
NOVARTIS AND EMPLOYMENT
We employ over 1,300 people in the UK and our work opportunities are gaining national recognition – we are proud to have been awarded the exclusive 'Top Employer’ certification for exceptional employee offerings six years in a row (2014-2019).
We value local expertise and talent; Novartis has an exciting future talent programme with placements for undergraduates, graduates and apprenticeships.
To find out more about working at Novartis, and our culture, please see our Careers pages.
COMMITMENT TO RESEARCH AND DEVELOPMENT
At Novartis we are committed to using science-based innovation to help address some of society’s most challenging healthcare issues.
Since 2014, we have invested over £200 million on research and development in the UK (excluding phase IV trials).1
Within our Innovative Medicines division, our work covers multiple disease areas including: oncology, cardiology, respiratory, immunology, hepatology and dermatology, neuroscience and ophthalmology.
For more information about how Novartis works within these disease areas, please visit this page.
Clinical trials are fundamental to the development of innovative medicines, help improve and extend patients’ lives and enable earlier access to latest medical research. We are passionate about contributing to life sciences in the UK and support over 10% of all clinical trials in this country – that’s more than any other pharmaceutical company.1 We have directly supported over 1,000 clinical trial sites in the UK, trialling our medicines in over 60 disease areas.2,3For more information about our medical research please visit this page.
SUPPORTING PATIENTS IN THE UK
We are proud to work in partnership with the NHS and patient advocacy groups to identify new ways to improve patient care in the UK. We work closely with patient groups and have been ranked as having the best patient group relationships in the UK, compared to other leading pharmaceutical companies.4
We have a long history of collaboration with the NHS – we work closely with our NHS partners to find sustainable solutions that transform patient care and improve patient experiences and outcomes. We have been involved in over 140 joint working initiatives with the NHS across the UK since 2011.